首页 | 本学科首页   官方微博 | 高级检索  
   检索      

VCTDSA联合CT 灌乌司他丁联合硝苯地平控释片对ESWL 术后肾功能的保护作用
引用本文:吴鹏,高岩,毕宏远,任重霖,李伟东.VCTDSA联合CT 灌乌司他丁联合硝苯地平控释片对ESWL 术后肾功能的保护作用[J].现代生物医学进展,2014,14(4):761-764.
作者姓名:吴鹏  高岩  毕宏远  任重霖  李伟东
作者单位:哈尔滨医科大学附属第四医院
基金项目:黑龙江省科技厅科技攻关项目(GC09C408-3)
摘    要:目的:观察乌司他丁(商品名天普洛安)和硝苯地平控释片(商品名拜新同)对体外冲击波碎石术(ESWL)所致急性肾功能损害 的保护作用。方法:将80 例接受ESWL治疗的肾结石患者,随机分为天普洛安组、拜新同组、天普洛安和拜新同联合组以及对照 组,每组20 例。检测并比较ESWL 前1 d 和后1、3、5 d 患者尿丙二醛(MDA)、N- 乙酰-beta-D- 氨基葡萄糖苷酶/ 肌酐(NAG/Cr)和 24 h尿beta2-微球蛋白(beta2-MG)的变化。结果:EWSL术后第1 天,对照组MDA、NAG/Cr和茁2-MG 水平均明显高于术前(P<0.05), 且随着术后时间的延长,患者MDA、NAG/Cr 和beta2-MG 水平呈逐渐下降趋势,术后第1、3、5 天治疗组MDA、NAG/Cr 和beta2-MG 数值均明显低于相同时点对照组(P<0. 05)。术后第1、3 天,联合用药组MDA、NAG/Cr和beta2-MG 水平明显低于单独用药的两组 (乌司他丁组和拜新同组)(P<0.05),第5 天联合用药组MDA、NAG/Cr 和beta2-MG 水平与单独用药的两组(乌司他丁组和拜新同 组)比较均无明显差异(P>0.05),单独用药的两组(乌司他丁组和拜新同组)之间在相同时点MDA、NAG/Cr 和beta2-MG 水平无明显 差异。结论:乌司他丁可显著减轻ESWL所致的肾损伤,与钙离子拮抗剂联合用药效果更佳。

关 键 词:肾结石  体外冲击波碎石术  乌司他丁  硝苯地平控释片

Study on the Protective Effect of Ulinastatin Combined with Nifedipine Controlled Release Tablets on the Renal Function after the ESWL
WU Peng,GAO Yan,BI Hong-yuan,REN Zhong-lin,LI Wei-dong.Study on the Protective Effect of Ulinastatin Combined with Nifedipine Controlled Release Tablets on the Renal Function after the ESWL[J].Progress in Modern Biomedicine,2014,14(4):761-764.
Authors:WU Peng  GAO Yan  BI Hong-yuan  REN Zhong-lin  LI Wei-dong
Abstract:Objective:Studying on the protective effect of Ulinastatin combined with Nifedipine Controlled Release Tablets on the renal function after the ESWL.Methods:80 patients accepted ESWL treatment were randomly divided into Ulinastatin group, Nifedipine group, combined group and control group, with 20 patients in each group. We measured the MDA and NAG/Cr at One day before the operation and the first day, third day, the fifth day after the operation , also measured the beta2-MG during the postoperative 24 hours.Results:On the first day after ESML, the MDA, NAG/Cr and beta2-MG levels of control group were significantly higher than those pre-operation (P<0.05), and presented downtrend with the increase of time, the MDA, NAG/Cr and beta2-MG levels of treatment groups on the first day, third day and fifth day after operation were significantly lower than those of the control group (P<0.05). On the first day and the third day after operation, the MDA, NAG/Cr and beta2-MG levels of combined group were significantly lower than the other treatment group(Ulinastain group and Nifedipine group)(P<0.05), which showed no significant difference on the fifth day after operation. The separate groups (Ulinastain group and Nifedipine group) showed no significant difference at the same time.Conclusion:Ulinastatin had the function of eliminate free radicals and relieve peroxide of lipid, which could lighten the kidney damage and the efficacy of ulinastatincombined with Calciumantagonists was better.
Keywords:Kidney stones  Extracorporeal shock wave lithotripsy  Ulinastatin  Nifedipine Controlled Release Tablets
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号